title: Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.
authors.forename: M N
authors.initials: MN
authors.lastname: Potenza
authors.forename: S
authors.initials: S
authors.lastname: Wasylink
authors.forename: J G
authors.initials: JG
authors.lastname: Longhurst
authors.forename: C N
authors.initials: CN
authors.lastname: Epperson
authors.forename: C J
authors.initials: CJ
authors.lastname: McDougle
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001569:Benzodiazepines; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D019233:Retreatment; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*; D017211:Treatment Failure
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D005473:Fluoxetine; D000077152:Olanzapine; D010890:Pirenzepine; D017367:Selective Serotonin Reuptake Inhibitors